How many institutions held RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in Q4 2021?

91 institutional investors reported RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) for Q4 2021. Use the holders table for investor-level position and value details.

RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

Q: What does CUSIP 75955J402 represent in this 13F holders report?

CUSIP 75955J402 is the security identifier for RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) used to aggregate holder disclosures.

CUSIP: 75955J402

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock ($.001 par value)
Shares outstanding: 74,702,121
Total 13F shares: 20,739,885
Share change: +10,697,808
Total reported value: $467,189,248
Put/Call ratio: 60%
Price per share: $22.53
Number of holders: 91
Value change: +$239,138,409
Number of buys: 45
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 75955J402:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	2.1%	1,538,026	$40,312,000	—	30 Sep 2021	13F
VR Adviser, LLC	13F	Company	1.9%	1,387,720	$36,372,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	1.6%	1,210,241	$31,721,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	1.2%	914,723	$23,975,000	—	30 Sep 2021	13F
PARSONS CAPITAL MANAGEMENT INC/RI	13F	Company	0.63%	472,974	$12,397,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.6%	449,337	$11,777,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.5%	375,852	$9,851,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.44%	325,871	$8,541,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.34%	254,580	$6,673,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.34%	253,703	$6,649,000	—	30 Sep 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.33%	243,007	$6,369,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.29%	220,000	$5,766,000	—	30 Sep 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	0.27%	200,996	$5,268,000	—	30 Sep 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.27%	200,000	$5,242,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.26%	197,934	$5,188,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.22%	163,205	$4,278,000	—	30 Sep 2021	13F
COWEN AND COMPANY, LLC	13F	Company	0.21%	159,633	$4,184,000	—	30 Sep 2021	13F
MANGROVE PARTNERS IM, LLC	13F	Company	0.21%	159,168	$4,172,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.15%	112,938	$2,961,000	—	30 Sep 2021	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.13%	100,000	$2,621,000	—	30 Sep 2021	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.13%	100,000	$2,621,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.13%	98,500	$2,582,000	—	30 Sep 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.12%	89,400	$2,343,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.12%	86,082	$2,257,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.08%	60,715	$1,592,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	53,204	$1,394,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	41,257	$1,082,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	34,830	$913,000	—	30 Sep 2021	13F
Spotlight Asset Group, Inc.	13F	Company	0.04%	30,265	$793,000	—	30 Sep 2021	13F
MEYER HANDELMAN CO	13F	Company	0.04%	28,378	$744,000	—	30 Sep 2021	13F
Pegasus Asset Management, Inc.	13F	Company	0.04%	26,958	$707,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.03%	26,000	$681,000	—	30 Sep 2021	13F
Ikarian Capital, LLC	13F	Company	0.03%	20,743	$544,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.03%	20,100	$527,000	—	30 Sep 2021	13F
CSS LLC/IL	13F	Company	0.02%	18,359	$481,000	—	30 Sep 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.02%	18,117	$475,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	17,900	$469,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	17,656	$463,000	—	30 Sep 2021	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.02%	17,606	$463,000	—	30 Sep 2021	13F
Jump Financial, LLC	13F	Company	0.02%	16,900	$443,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	16,481	$432,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	15,826	$415,000	—	30 Sep 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.02%	15,500	$406,000	—	30 Sep 2021	13F
World Investment Advisors	13F	Company	0.02%	14,200	$372,000	—	30 Sep 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	14,060	$369,000	—	30 Sep 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	13,053	$342,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	12,280	$322,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	10,786	$283,000	—	30 Sep 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.01%	10,000	$261,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	9,811	$257,000	—	30 Sep 2021	13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q4 2021

As of 31 Dec 2021, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,739,885 shares. The largest 10 holders included VR Adviser, LLC, RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., Vivo Capital, LLC, Avidity Partners Management LP, and GREAT POINT PARTNERS LLC. This page lists 91 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.